Chemical Compound

2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; GW591080X; Vilanterol Trifenatate Stage 2 Starting Material

CAS Registry Number 452339-73-0
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; GW591080X; Vilanterol Trifenatate Stage 2 Starting Material 结构式
Primary record

2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; GW591080X; Vilanterol Trifenatate Stage 2 Starting Material

库存
8,934 克
纯度
98.6 %
CAS
452339-73-0

化合物标识与属性

CAS
452339-73-0
PubChem CID
10933894
SMILES
CC1(OCC2=C(O1)C=CC(=C2)[C@@H]3CNC(=O)O3)C
Canonical SMILES
CC1(C)OCc2cc([C@@H]3CNC(=O)O3)ccc2O1

名称与同义词

  • 452339-73-0
  • Vilanterol Intermediates
  • Vilanterol Impurity 29
  • Vilanterol Impurity 41
  • RefChem:69620
  • (5R)-2-Oxazolidinone,
  • (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
  • 6QWT6YYP3F
  • MFCD21362968
  • (R)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one
  • SCHEMBL925446
  • C13H15NO4
  • KS-00000LGB
  • JUEBDVANOFZMMX-NSHDSACASA-N
  • DTXSID601164190
  • AMY30026
  • BCP24279
  • CS-M2588
  • ZINC34571268
  • AKOS027339713
  • ACN-041383
  • CID10933894
  • 2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-
  • AC-30866
  • BB067408
  • DS-12375
  • SY233776
  • (R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
  • F11523
  • (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone
  • 5-(2,2-diMethyl-4H-1,3-benzodio xin-6-yl)
  • A852183
  • (5R)-2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)
  • (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)oxazolidin-2-one
  • 2-Oxazolidinone,5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-,5R-
  • (5R)-5-(2,2-Dimethyl-2H,4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
  • (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-on e
  • (5R)-5-(2.2-Dimethyl-4H-1.3-benzodioxin-6-yl)-1.3-oxazolidin-2-one
  • (R)-5-(2,2-Dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-oxazolidinone
  • 5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone, (5R)-
  • (5R)-5-(2,2-dimethyl-2,4-dihydro-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
  • (5R)-5-(2,2-Dimethyl-4H-1,3-benZodioxin-6-yl)-1,3-oxaZolidin-2-one, 98%
  • (5S)-5-(8,8-dimethyl-7,9-dioxabicyclo[4.4.0]deca-2,4,11-trien-3-yl)-1,3-oxazolidin-2-one
  • 2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one; (R)-5-(2,2-Dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one; (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxazolidinone; GW591080X; Vilanterol Trifenatate Stage 2 Starting Material
  • 807-351-6